Evidence-Based Medicine
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 28, 2014; 20(44): 16702-16706
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16702
Figure 1
Figure 1 Expressions of Gastrokine 1 protein in the four groups. A: superficial gastritis; B: atrophic gastritis; C: gastric cancer; D: Cancer-adjacent. aP < 0.05 vs superficial gastritis group; bP < 0.05 vs the atrophic gastritis group.
Figure 2
Figure 2 Immunohistochemical staining results in the four groups. A: Superficial gastritis; B: Atrophic gastritis; C: Gastric cancer; D: Cancer-adjacent.
Figure 3
Figure 3 Expressions of Gastrokine 1 mRNA in the four groups. aP < 0.05 vs superficial gastritis group; cP < 0.01 vs superficial gastritis group; dP < 0.01 vs gastric cancer group; eP < 0.01 vs cancer-adjacent group.
Figure 4
Figure 4 Expressions of Gastrokine 1 mRNA in diffuse type and intestinal type gastric cancer. cP < 0.01 vs superficial gastritis group; dP < 0.01 vs diffuse type gastric cancer.